In the new American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults, there is acknowledgment of inclusion of the TERT promoter mutation in assessment of the overall mutational burden in thyroid cancers (74). The gene discussed is TERT; the disease is thyroid gland disorder.